Description

According to a report by StrategyHelix, the global OTC drugs, medical devices and diagnostics market is set to increase by US$ 154.4 billion during 2022-2028, growing at a CAGR of 6.9% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for OTC drugs, medical devices and diagnostics. The global OTC drugs, medical devices and diagnostics market is segmented on the basis of product, disease, and region. On the basis of product, the global OTC drugs, medical devices and diagnostics market has been segmented into OTC drugs, OTC medical devices. The OTC drugs segment is estimated to account for the largest share of the global OTC drugs, medical devices and diagnostics market. By disease, the global OTC drugs, medical devices and diagnostics market has been segmented into cardiovascular diseases (CVDs), diabetes, ENT disorders, gastrointestinal disorders, obesity, orthopedic disorders, respiratory disorders, skin diseases, sleep disorders, others. The diabetes segment held the largest revenue share in 2021. Geographically, the global OTC drugs, medical devices and diagnostics market is segmented into Asia Pacific, Europe, USA, Rest of the World (RoW). Globally, USA made up the largest share of the OTC drugs, medical devices and diagnostics market.

The OTC medical devices and diagnostics market is further segmented into diagnostic devices and kits, and self-care devices and wearables. The self-care devices and wearables segment held the largest share of the global OTC drugs, medical devices and diagnostics market in 2021 and is anticipated to hold its share during the forecast period. Furthermore, the OTC drugs and nutritional products/supplements market has been categorized into pharmaceutical OTC drugs, and vitamin and mineral supplements. In 2021, the pharmaceutical OTC drugs segment made up the largest share of revenue generated by the OTC drugs, medical devices and diagnostics market.

The global OTC drugs, medical devices and diagnostics market is highly competitive. Key companies profiled in the report include 3M Company, Abbott Laboratories, AbbVie Inc., AKRON Inc., Amgen Inc., Asahi Kasei Corporation, Aspen Pharmacare Holdings Limited, AstraZeneca plc, Baxter International Inc., Bayer AG, Celgene Corporation, Eli Lilly and Company, Johnson & Johnson, Shanghai Pharmaceuticals Holding Co. Ltd., Taisho Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd. Competitive landscape gives a description of the competitive nature of the global OTC drugs, medical devices and diagnostics market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the OTC drugs, medical devices and diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: OTC drugs, OTC medical devices
Disease: cardiovascular diseases (CVDs), diabetes, ENT disorders, gastrointestinal disorders, obesity, orthopedic disorders, respiratory disorders, skin diseases, sleep disorders, others
Region: Asia Pacific, Europe, USA, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: 3M Company, Abbott Laboratories, AbbVie Inc., AKRON Inc., Amgen Inc., Asahi Kasei Corporation, Aspen Pharmacare Holdings Limited, AstraZeneca plc, Baxter International Inc., Bayer AG, Celgene Corporation, Eli Lilly and Company, Johnson & Johnson, Shanghai Pharmaceuticals Holding Co. Ltd., Taisho Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global OTC drugs, medical devices and diagnostics market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. OTC drugs, medical devices and diagnostics market overview
Part 3. Market breakdown by product
– OTC drugs
– OTC medical devices
Part 4. Market breakdown by disease
– Cardiovascular diseases (CVDs)
– Diabetes
– ENT disorders
– Gastrointestinal disorders
– Obesity
– Orthopedic disorders
– Respiratory disorders
– Skin diseases
– Sleep disorders
– Others
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– USA
– Rest of the World (RoW)
Part 6. Key companies
– 3M Company
– Abbott Laboratories
– AbbVie Inc.
– AKRON Inc.
– Amgen Inc.
– Asahi Kasei Corporation
– Aspen Pharmacare Holdings Limited
– AstraZeneca plc
– Baxter International Inc.
– Bayer AG
– Celgene Corporation
– Eli Lilly and Company
– Johnson & Johnson
– Shanghai Pharmaceuticals Holding Co., Ltd.
– Taisho Pharmaceutical Co., Ltd.
– Takeda Pharmaceutical Co., Ltd.
– Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer